Invasive pneumococcal disease in non-Indigenous people in north Queensland, 2001-2009

Area of Science:

• Public Health
• Epidemiology
• Vaccinology

Background:

• Invasive pneumococcal disease (IPD) remains a significant public health concern.
• Vaccination is a key strategy for controlling IPD.
• Understanding vaccine impact is crucial for public health policy.

Purpose of the Study:

• To evaluate the impact of 7-valent pneumococcal conjugate vaccine (7vPCV) and 23-valent pneumococcal polysaccharide vaccine (23vPPV) on IPD incidence in non-Indigenous individuals in North Queensland.
• To assess the proportion of IPD cases that were potentially preventable by vaccination post-rollout.

Main Methods:

• A comparative study analyzing IPD trends before (2001-2004) and after (2006-2009) vaccine introduction.
• Data collected on IPD incidence and serotypes in the non-Indigenous population of North Queensland.
• Statistical analysis to determine significant changes in IPD rates.

Main Results:

• Overall IPD incidence decreased by 34% post-vaccination (P < 0.05).
• 7vPCV serotype IPD incidence dropped by 77% across all age groups.
• Significant declines observed in children (<5 years) and adults (15-64 years, ≥65 years) for vaccine-serotype IPD.
• An increase in 23vPPV-uncovered serotypes was noted in adults aged 15-64 years.

Conclusions:

• The 7vPCV demonstrated a substantial indirect protective effect against IPD in adults.
• The 23vPPV showed a direct effect in older adults (≥65 years).
• Future conjugate vaccines hold potential for greater IPD prevention through combined direct and indirect mechanisms.